A self-assembling nanoparticle designed by a UConn professor is the key component of a potent new malaria vaccine that is showing promise in early tests.
Bio & Medicine
Sep 4, 2014
0
0
A study illustrates 'high conservation potential' of vaccines for endangered wild primates devastated by viral disease, but highlights need for access to captive chimpanzees so vaccines can be trialled before being administered ...
Plants & Animals
May 26, 2014
1
0
Vaccines combat diseases and protect populations from outbreaks, but the life-saving technology leaves room for improvement. Vaccines usually are made en masse in centralized locations far removed from where they will be ...
Bio & Medicine
Jan 7, 2014
0
0
As many as one in 50 people around the world is infected with some type of hepacivirus or pegivirus, including up to 200 million with hepatitis C virus (HCV), a leading cause of liver failure and liver cancer. There has been ...
Cell & Microbiology
Apr 22, 2013
0
0
(Phys.org) —Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine? That's the question biologists at UC San Diego sought to answer after they demonstrated last May ...
Cell & Microbiology
Apr 19, 2013
0
0
(Phys.org) —Biomedical engineering researchers at the University of Arkansas have encapsulated two types of protein antigens in chitosan and demonstrated that the combined material enables or improves three important immune ...
Biochemistry
Mar 5, 2013
0
0
Researchers at The University of Texas at Austin have developed a menu of 61 new strains of genetically engineered bacteria that may improve the efficacy of vaccines for diseases such as flu, pertussis, cholera and HPV.
Biotechnology
Jan 15, 2013
5
0
In mammals such as rodents that raise their young as a group, infants will nurse from their mother as well as other females, a dynamic known as allosuckling. Ecologists have long hypothesized that allosuckling lets newborns ...
Plants & Animals
Jan 9, 2013
0
0
(Phys.org)—A joint research effort by the Friedrich-Loeffler-Institute and pharmaceutical company CureVac, both based in Germany, has resulted in the creation of a new type of flu vaccine. The vaccine, as the team describes ...
(Phys.org) -- A new method for looking at how proteins fold inside mammal cells could one day lead to better flu vaccines, among other practical applications, say Cornell researchers.
Biochemistry
Jul 26, 2012
1
0
